337 related articles for article (PubMed ID: 15504945)
21. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study.
Thong MS; Kaptein AA; Benyamini Y; Krediet RT; Boeschoten EW; Dekker FW;
Am J Kidney Dis; 2008 Jul; 52(1):111-7. PubMed ID: 18511166
[TBL] [Abstract][Full Text] [Related]
22. Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease.
Joki N; Tanaka Y; Ishikawa H; Takahashi Y; Iwakura Y; Masuda H; Inishi Y; Hase H
Am J Nephrol; 2009; 29(5):420-5. PubMed ID: 18997458
[TBL] [Abstract][Full Text] [Related]
23. Serum CRP levels in pre-dialysis patients.
Razeghi E; Parkhideh S; Ahmadi F; Khashayar P
Ren Fail; 2008; 30(2):193-8. PubMed ID: 18300120
[TBL] [Abstract][Full Text] [Related]
24. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis.
den Elzen WP; van Manen JG; Boeschoten EW; Krediet RT; Dekker FW
Nephrol Dial Transplant; 2006 Jun; 21(6):1588-95. PubMed ID: 16449284
[TBL] [Abstract][Full Text] [Related]
25. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
[TBL] [Abstract][Full Text] [Related]
26. Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis.
Moreira AC; Gaspar A; Serra MA; Simões J; Lopes da Cruz J; Amaral TF
J Ren Nutr; 2007 May; 17(3):205-13. PubMed ID: 17462553
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F
J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients.
Kanwar M; Hashem M; Rosman H; Kamalakannan D; Cheema A; Ali A; Gardin J; Maciejko JJ
Am J Cardiol; 2006 Nov; 98(9):1283-7. PubMed ID: 17056347
[TBL] [Abstract][Full Text] [Related]
29. Renal amyloidosis is associated with increased mortality in hemodialysis patients.
Sengul S; Arat Z; Ozdemir FN
Artif Organs; 2004 Sep; 28(9):846-52. PubMed ID: 15320948
[TBL] [Abstract][Full Text] [Related]
30. Infective endocarditis in maintenance hemodialysis patients: fifteen years' experience in one medical center.
Chang CF; Kuo BI; Chen TL; Yang WC; Lee SD; Lin CC
J Nephrol; 2004; 17(2):228-35. PubMed ID: 15293522
[TBL] [Abstract][Full Text] [Related]
31. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
32. Correlates of habitual physical activity in chronic haemodialysis patients.
Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
[TBL] [Abstract][Full Text] [Related]
33. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
34. [Serum uric acid and C-reactive protein levels in patients with chronic kidney disease].
Caravaca F; Martín MV; Barroso S; Cancho B; Arrobas M; Luna E; Sánchez-Casado E
Nefrologia; 2005; 25(6):645-54. PubMed ID: 16514905
[TBL] [Abstract][Full Text] [Related]
35. Clinical consequences of intermittent elevation of C-reactive protein levels in hemodialysis patients.
Sezer S; Külah E; Ozdemir FN; Tutal E; Arat Z; Haberal M
Transplant Proc; 2004; 36(1):38-40. PubMed ID: 15013294
[TBL] [Abstract][Full Text] [Related]
36. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis.
Lam MF; Leung JC; Lo WK; Tam S; Chong MC; Lui SL; Tse KC; Chan TM; Lai KN
Nephrol Dial Transplant; 2007 May; 22(5):1445-50. PubMed ID: 17277343
[TBL] [Abstract][Full Text] [Related]
37. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
[TBL] [Abstract][Full Text] [Related]
38. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
39. Serum mannose-binding lectin levels in maintenance hemodialysis patients: impact on all-cause mortality.
Satomura A; Endo M; Fujita T; Ohi H; Ohsawa I; Fuke Y; Matsumoto K; Sudo S; Matsushita M; Fujita T
Nephron Clin Pract; 2006; 102(3-4):c93-9. PubMed ID: 16282701
[TBL] [Abstract][Full Text] [Related]
40. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.
Bradbury BD; Critchlow CW; Weir MR; Stewart R; Krishnan M; Hakim RH
Nephrol Dial Transplant; 2009 Mar; 24(3):919-25. PubMed ID: 18840893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
